Merck & Co., Inc. (MRK)
NYSE · Healthcare
Merck & Co., Inc. Revenue 2007–2025
Merck & Co., Inc. annual/quarterly revenue history and growth rate from 2007 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Merck & Co., Inc. revenue for the quarter ending March 31, 2026 was 16.3 B, a 4.87% increase year-over-year.
- Merck & Co., Inc. revenue for the twelve months ending March 31, 2026 was 64.9 B, a 0.61% increase year-over-year.
- Merck & Co., Inc. annual revenue for 2025 was 65.0 B, a 1.31% increase from 2024.
- Merck & Co., Inc. annual revenue for 2024 was 64.2 B, a 6.74% increase from 2023.
- Merck & Co., Inc. annual revenue for 2023 was 60.1 B, a 1.40% increase from 2022.
- Merck & Co., Inc. annual revenue for 2022 was 59.3 B.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Merck & Co. Inc. Earnings — FAQ
Merck & Co. Inc. (MRK) earnings over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MRK's earnings history?
The chart and table above show Merck & Co. Inc.'s earnings by year and by quarter, including the growth rate.